[
  {
    "ts": "2025-12-05T13:30:00+00:00",
    "headline": "Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats",
    "summary": "PARSIPPANY, N.J., December 05, 2025--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in cats. Designed to provide three months of OA pain relief with a single injection, Portela targets anti-nerve growth factor (NGF), which is a key mediator of OA pain and inflammation.",
    "url": "https://finance.yahoo.com/news/zoetis-receives-health-canada-approval-133000277.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "b3da8306-320d-31d9-89a3-46256ca76e28",
      "content": {
        "id": "b3da8306-320d-31d9-89a3-46256ca76e28",
        "contentType": "STORY",
        "title": "Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats",
        "description": "",
        "summary": "PARSIPPANY, N.J., December 05, 2025--Zoetis Inc. today announced that Health Canada has approved Portela™ (relfovetmab injection) for the alleviation of pain associated with osteoarthritis (OA) in cats. Designed to provide three months of OA pain relief with a single injection, Portela targets anti-nerve growth factor (NGF), which is a key mediator of OA pain and inflammation.",
        "pubDate": "2025-12-05T13:30:00Z",
        "displayTime": "2025-12-05T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/e9a075748cbbcfbdd42b51750d0be30d",
          "originalWidth": 1035,
          "originalHeight": 387,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/09HUsmJX2rNoO2yBBfzfDA--~B/aD0zODc7dz0xMDM1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e9a075748cbbcfbdd42b51750d0be30d.cf.webp",
              "width": 1035,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XRroRCCebjcCicNCgYQy5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e9a075748cbbcfbdd42b51750d0be30d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-health-canada-approval-133000277.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zoetis-receives-health-canada-approval-133000277.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZTS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]